Journal of Generic Medicines - Figure 1 for article: Patent expiries in the US statin market: Generics to slash market size by 80 per cent over the next ten years

Journal of Generic Medicines

FROM:

Patent expiries in the US statin market: Generics to slash market size by 80 per cent over the next ten years

Duncan Emerton

Figure 1.

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Likely scenarios for switching from Zocor to generic simvastatin, and the effect of generic atorvastatin from 2011 on generic simvastatin sales
Source: Datamonitor

Next figureFigure and tables index

BACK TO ARTICLE

FIGURE 1

Patent expiries in the US statin market: Generics to slash market size by 80 per cent over the next ten years

Figure 1.